Related Experiment Video

Updated: Aug 7, 2026

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature
10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature

Published on: December 26, 2017

From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy: a detective story

Toshio Miyata1, Kiyoshi Kurokawa, Charles van Ypersele de Strihou

  • 1Institute of Medical Sciences, Tokai University, Kanagawa 259-1193, Japan. t-miyata@is.icc.u-tokai.ac.jp

Current Drug Targets. Immune, Endocrine and Metabolic Disorders
|September 24, 2005
PubMed

Insights

Oxidative protein damage in diabetic nephropathy can be reversed by certain antihypertensive drugs. This review explores these modifications and their regression, opening new avenues for renoprotective agent development.

Area of Science:

  • Biochemistry
  • Pathophysiology
  • Pharmacology

Background:

  • Oxidative tissue damage is a complex process implicated in human diseases.
  • Proteins are key targets for studying oxidative damage and disease mechanisms.
  • Understanding protein modifications aids in developing antioxidants and evaluating drug efficacy.

Purpose of the Study:

  • To review oxidative protein modifications in diabetic nephropathy.
  • To examine the regression of these modifications with renoprotective antihypertensive agents.
  • To explore new therapeutic strategies for diabetic nephropathy based on protein biochemistry.

Main Methods:

  • Literature review focusing on oxidative protein modifications.
  • Analysis of existing clinical drugs interfering with oxidative protein damage.
  • Examination of antihypertensive agents' effects on diabetic nephropathy protein damage.

Main Results:

  • Diabetic nephropathy involves specific oxidative protein modifications.
  • Renoprotective antihypertensive agents can regress these protein modifications.
  • The chemical structure of drugs influences their mechanism against oxidative damage.

Conclusions:

  • Insights into protein modification biochemistry offer new therapeutic targets.
  • Development of novel renoprotective agents for diabetic nephropathy is a promising area.
  • Further testing is required to validate the hypothetical approaches discussed.

More Related Videos

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on: May 10, 2024

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...